OncoTAb, Inc., a University of North Carolina at Charlotte (UNCC) spin-out company, announced that CEO Rahul Puri will present the study findings of a non-invasive blood test to aid in the early detection of breast cancer in women with dense breast tissue at the 9th Annual OneMedForum in San Francisco. The presentation will take place today, January 12 at 2:45 p.m. and again on January 13 at 11:00 a.m. at the San Francisco Marriot Marquis.